GLAND
PharmaceuticalsGland Pharma Limited
NSE: GLANDBSE: 543245ISIN: INE068V01023
₹2,922.30
-24.60 · -0.83%
As of 11 Sept 2026
Open
₹2,940.00
High
₹2,950.10
Low
₹2,882.00
Prev Close
₹2,946.90
52W High
₹3,042.00
52W Low
₹1,573.60
Volume
3.89 L
Mkt Cap
₹48,174 Cr
Fundamentals
Valuation & profitability
Market Cap
₹48,174 Cr
P/E Ratio
42.2
EPS (TTM)
₹69.25
Book Value
₹530.00
Dividend Yield
1.01%
ROCE
13.6%
ROE
9.26%
Sales Growth
18%
Face Value
₹1.00
Key highlights
Auto-generated from live data
- Trades at a P/E of 42.2, with a return on equity (ROE) of 9.26%.
- GLAND is trading above 4 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
- Year-to-date it is up 73.86%, and up 74.78% over the past year.
- At ₹2,922.30 it sits about 92% of the way up its 52-week range (₹1,573.60–₹3,042.00).
- Offers a dividend yield of 1.01%.
- Market capitalisation stands at ₹48,174 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern
Shareholding data syncs daily.
Performance
Stock returns vs Nifty 50
10D
+3.06%
Nifty -1.98%
20D
+5.59%
Nifty -2.76%
50D
+24.87%
Nifty -1.38%
100D
+32.62%
Nifty +1.41%
200D
+63.79%
Nifty -8.32%
YTD
+73.86%
Nifty -10.09%
52W
+74.78%
Nifty -10.42%
Moving averages
Simple moving averages vs current price
SMA 10-Day
₹2,929.85Below
SMA 20-Day
₹2,891.94Above
SMA 50-Day
₹2,691.68Above
SMA 100-Day
₹2,410.22Above
SMA 200-Day
₹2,072.80Above
Price ranges
Where the price sits in each window
10-Day range₹2,922.30
₹2,803.00₹3,042.00
20-Day range₹2,922.30
₹2,776.10₹3,042.00
50-Day range₹2,922.30
₹2,351.10₹3,042.00
200-Day range₹2,922.30
₹1,573.60₹3,042.00
YTD range₹2,922.30
₹1,573.60₹3,042.00
52-Week range₹2,922.30
₹1,573.60₹3,042.00
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Up On 11 Aug, 2026 : 2808.00 ~ 2685.00SUPPORT
Unfilled Gap Up On 18 May, 2026 : 2034.00 ~ 1950.00SUPPORT
Annual financials
Revenue, profit & EPS by financial year
| Year | Revenue | Net Profit | EPS | NPM |
|---|---|---|---|---|
| Mar 2023 | ₹3,617 Cr | ₹776 Cr | ₹47.11 | 21.45% |
| Mar 2022 | ₹4,401 Cr | ₹1,212 Cr | ₹73.78 | 27.54% |
| Mar 2021 | ₹3,463 Cr | ₹997 Cr | ₹60.94 | 28.79% |
| Mar 2021 | ₹3,463 Cr | ₹997 Cr | ₹60.94 | 28.79% |
| Mar 2020 | ₹2,633 Cr | ₹773 Cr | ₹0.00 | 29.36% |
| Mar 2020 | ₹2,633 Cr | ₹773 Cr | ₹0.00 | 29.36% |
| Mar 2019 | ₹2,044 Cr | ₹452 Cr | ₹0.00 | 22.11% |
| Mar 2018 | ₹1,620 Cr | ₹321 Cr | ₹0.00 | 19.81% |
| Mar 2017 | ₹1,479 Cr | ₹414 Cr | ₹0.00 | 27.99% |
| Mar 2016 | ₹1,348 Cr | ₹314 Cr | ₹0.00 | 23.29% |
| Mar 2015 | ₹994 Cr | ₹209 Cr | ₹0.00 | 21.03% |
| Mar 2014 | ₹991 Cr | ₹224 Cr | ₹0.00 | 22.6% |
Peer comparison
Other companies in Pharmaceuticals
| Company | P/E | Book Value | Sales Growth |
|---|---|---|---|
| SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD. | 39.1 | ₹98.33 | 10.1% |
| MARKSANS MARKSANS PHARMA LTD. | 23.8 | ₹11.85 | 5.8% |
| MOREPENLAB MOREPEN LABORATORIES LTD. | 20.81 | ₹6.43 | 16.6% |
| NEULANDLAB NEULAND LABORATORIES LTD. | 23.48 | ₹542.16 | 9.35% |
| GUFICBIO Gufic BioSciences Ltd. | 24.16 | ₹10.85 | 20.41% |
| DIVISLAB DIVI'S LABORATORIES LTD. | 41.01 | ₹266.77 | 9.47% |
| DRREDDY DR.REDDY'S LABORATORIES LTD. | 19.73 | ₹852.69 | 1.07% |
| RPGLIFE RPG LIFE SCIENCES LTD. | 17.14 | ₹105.02 | 5.73% |
| ZYDUSLIFE Zydus Lifesciences Ltd | 8.23 | ₹166.00 | 5% |
| SMSPHARMA SMS PHARMACEUTICALS LTD. | 9.58 | ₹42.07 | -8.73% |
| CIPLA CIPLA LTD. | 15.36 | ₹209.71 | 0.7% |
Bulk & block deals
Recent large transactions
| Date | Client | Type | Qty | Price |
|---|---|---|---|---|
| 21 Apr 2022 | NICOMAC MACHINERY PRIVATE LIMITED | SALE | 53,79,343 | ₹3,200.66 |
| 02 Sept 2021 | GOLDMAN SACHS FUNDS GOLDMAN SACHS INDIA EQUITY PORTFOLIO | PURCHASE | 4,00,293 | ₹3,903.05 |
| 02 Sept 2021 | GOLDMAN SACHS INDIA FUND LIMITED | SALE | 4,00,293 | ₹3,903.05 |
Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.